SHP-2 phosphatase contributes to KRAS-driven intestinal oncogenesis but prevents colitis-associated cancer development

This publication has 75 references indexed in Scilit:

• SHP‐2 Phosphatase Prevents Colonic Inflammation by Controlling Secretory Cell Differentiation and Maintaining Host‐Microbiota Homeostasis
  Journal of Cellular Physiology, 2016
• Wanderer, an interactive viewer to explore DNA methylation and gene expression data in human cancer
  Epigenetics & Chromatin, 2015
• Inflammation and colorectal cancer: colitis-associated neoplasia
  Seminars in Immunopathology, 2012
• Inflammation and p53: A Tale of Two Stresses
  Genes & Cancer, 2011
• IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer
  Cancer Cell, 2009
• Epithelial NEMO links innate immunity to chronic intestinal inflammation
  Nature, 2007
• Muc2-Deficient Mice Spontaneously Develop Colitis, Indicating That MUC2 Is Critical for Colonic Protection
  Gastroenterology, 2006
• SHP-2 Positively Regulates Myogenesis by Coupling to the Rho GTPase Signaling Pathway
  Molecular and Cellular Biology, 2004
• The ‘Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
  Trends in Biochemical Sciences, 2003
• Mutations in APC, Kirsten-ras, and p53—alternative genetic pathways to colorectal cancer
  Proceedings of the National Academy of Sciences, 2002